University of Pennsylvania Researches CBD products

By Frank G. Shineman

In 2017 a researcher at the University of Pennsylvania embarked on, first of all, a study to determine the accuracy of labeling of CBD products sold online. Most of their findings in this regard were quite surprising, resulting in disturbing revelations.

The Daily Chronic first published the findings on November 15, 2017. The principal revelation was quite disturbing- that as much as 70% of CBD products were badly mislabeled. Only 30 percent of the products tested contained percentages that were within ten percent of the amount listed on the label. Another disturbing fact uncovered was that some products advertised as THC- free actually contained detectable amounts of that same element.

Merry Jane reported on this same research conducted by University of Pennsylvania students. Their reporting was equally unsettling. They noted that the student researchers studied 84 different CBD products. They concluded that two-thirds of the tinctures and up to 90% of the vaporization liquids grossly misrepresented the actual amounts of CBD in the products.

Leafly reported indeed there are gross mislabeling errors throughout the CBD online market. It is true that even as the consumption of CBD products is growing exponentially, it is extremely important that this labeling fiasco must be solved.

Marcel Bonn-Miller is the researcher from the University of Pennsylvania who coordinated this research with two respected organizations. They were Americans for Safe Access and Johns Hopkins University. The study mentioned above of 84 CBD products was conducted between September and October 2016.

The radio station WTHR in Indiana recently interviewed a DEA official. They intended to gain insight into the prevailing attitude of the Federal government.
The DEA spokesman Mr. Rusty Payne, said the following, “We are in the midst of an opioid crisis in our country and that is our highest priority. People are not dying from CBD consumption, besides many would say that CBD is saving lives. Will we insert ourselves into the midst of that? Probably not.”